Creo Medical Group (LON:CREO – Get Free Report)‘s stock had its “house stock” rating reissued by Shore Capital Group in a report issued on Tuesday,Digital Look reports. They currently have a GBX 40 price target on the stock. Shore Capital Group’s target price would suggest a potential upside of 171.19% from the stock’s previous close.
Creo Medical Group Stock Up 1.7%
Shares of LON CREO opened at GBX 14.75 on Tuesday. The company has a debt-to-equity ratio of 8.20, a quick ratio of 2.19 and a current ratio of 3.22. The firm has a market capitalization of £60.84 million, a price-to-earnings ratio of -14.75 and a beta of 1.62. The stock has a 50 day moving average price of GBX 12.10 and a 200 day moving average price of GBX 12.20. Creo Medical Group has a 52-week low of GBX 9.52 and a 52-week high of GBX 18.50.
Creo Medical Group (LON:CREO – Get Free Report) last announced its quarterly earnings results on Friday, May 22nd. The company reported GBX (0.04) earnings per share (EPS) for the quarter. The firm had revenue of GBX 600 million during the quarter. Creo Medical Group had a net margin of 88.33% and a return on equity of 9.56%. Sell-side analysts expect that Creo Medical Group will post -10.0800005 earnings per share for the current year.
About Creo Medical Group
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.
Featured Articles
- Five stocks we like better than Creo Medical Group
- Why Walmart’s Rally May Need a Reset
- Cloud-flation: Dell’s On-Premise AI Bet Pays Off
- Alphabet Just Unveiled Its Most Ambitious AI Lineup Yet
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
